Charles River Laboratories International, Inc. (CRL) Q2 2013 Earnings Results

Charles River Laboratories Beats on EPS, Stock Up 1.74%

Charles River Laboratories reported an EPS of $0.73, slightly exceeding expectations. The positive surprise contributed to a stock increase of 1.74%. However, without additional details from management, it's unclear how this performance may influence future operations or strategy.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.73	N/A	+2.53%

Management

Management commentary

Tone: Unknown

No transcript is on record, and the analysis is based solely on numerical results.

Charles River Laboratories Beats on EPS, Stock Up 1.74%

Key numbers

Management commentary

Charles River Laboratories International, Inc.

More earnings this week

Charles River Laboratories Beats on EPS, Stock Up 1.74%

Key numbers

Management commentary